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Abstract
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent studies in human
populations suggest a strain specific genetic control of tuberculosis. To test for mycobacterial-strain specific genetic control
of susceptibility to infection under highly controlled experimental conditions, we performed a comparative genetic analysis
using the A/J- and C57BL/6J-derived recombinant congenic (RC) mouse panel infected with the Russia and Pasteur strains of
Mycobacterium bovis Bacille Calmette Gue´rin (BCG). Bacillary counts in the lung and spleen at weeks 1 and 6 post infection
were used as a measure of susceptibility. By performing genome-wide linkage analyses of loci that impact on tissue-specific
bacillary burden, we were able to show the importance of correcting for strain background effects in the RC panel. When
linkage analysis was adjusted on strain background, we detected a single locus on chromosome 11 that impacted on
pulmonary counts of BCG Russia but not Pasteur. The same locus also controlled the splenic counts of BCG Russia but not
Pasteur. By contrast, a locus on chromosome 1 which was indistinguishable from Nramp1 impacted on splenic bacillary
counts of both BCG Russia and Pasteur. Additionally, dependent upon BCG strain, tissue and time post infection, we
detected 9 distinct loci associated with bacillary counts. Hence, the ensemble of genetic loci impacting on BCG infection
revealed a highly dynamic picture of genetic control that reflected both the course of infection and the infecting strain. This
high degree of adaptation of host genetics to strain-specific pathogenesis is expected to provide a suitable framework for
the selection of specific host-mycobacteria combinations during co-evolution of mycobacteria with humans.
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Introduction
The primary cause of tuberculosis is the human pathogenic
bacterium Mycobacterium tuberculosis. The host cells of M. tuberculosis
are macrophages and the bacilli have developed numerous
adaptations to survive within these powerful immune effector
cells. For example, human pathogenic strains of M. tuberculosis
inactivate microbicidal superoxide via katalase [1], avoid the
detrimental effects of iNOS products [2], skew the anti-
mycobacterial response in macrophages towards production of
anti-inflammatory molecules [3,4], and favour necrosis over
apoptosis [5,6,7]. Interestingly, circulating strains of M. tuberculosis
may differ in their pathogenic potential [8,9]. Since humans and
M. tuberculosis have co-evolved over millennia, a question remains if
and to what extentM. tuberculosis has adapted to genetically distinct
hosts. Indeed, two studies conducted in ethnically mixed samples
detected a non-random association of M. tuberculosis strains with
distinct ethnic populations [10,11]. These observations are
supported by the results of several genetic association studies that
detected preferential associations between a Toll-like receptor 2
(TLR2) polymorphism and tuberculosis meningitis caused by
Beijing strains [12], as well as between variants of 59-lipoxygenase
(ALOX5) and pulmonary tuberculosis caused by M. africanum, but
not M. tuberculosis [13]. In addition, variants of the immunity-
related GTPase M (IRGM) were associated with protection from
pulmonary tuberculosis due to Euro-American strains of M.
tuberculosis [14]. Due to the complex interactions of M. tuberculosis
and humans in exposed populations, it is possible that those results
may have been confounded by unrecognized factors. In the
absence of independent replication studies, the question of strain
specific genetic effects as a consequence of M. tuberculosis human
co-evolution still awaits testing under carefully controlled condi-
tions.
M. bovis Bacille Calmette-Guerin (BCG) strains are phylogenetic
descendants of an ancestral BCG stock originally derived from
virulent M. bovis through in vitro propagation [15,16,17].
Attenuation of the original BCG stock occurred as a result of
deletions in the M. bovis genome, specifically the region of
difference 1 (RD1) [18,19]. Loss of RD1 is common across all
BCG strains, although additional genetic alterations have been
identified for each strain. BCG Russia and BCG Pasteur are
among the most phylogenetically distant BCG strains [15].
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Genetic events identified in BCG Russia include the deletion of
RD Russia (Rv3698) [20], an insertion mutation in the recA gene
(recA_D140*) [21], and the presence of an IS6110 element in the
promoter region of the phoP gene [15,22]. BCG Pasteur is
characterized by the loss of RD2, nRD18, and RD14 [23,24,25]
as well as a number of single point mutations and duplication
events [22,23,26,27]. Phenotypic differences between BCG
Pasteur and BCG Russia can therefore be tentatively linked to
these known changes in gene content and an unknown number of
point mutations. A number of unresolved questions surround the
BCG host interplay which is characterized by highly variable host
responsiveness. For example, the immunogenicity of the same
strain of BCG given to vaccinees of different genetic background
can vary tremendously [28,29] while host responses triggered by
different strains of BCG are equally divergent [30]. On a
population scale, BCG strains differ in the adverse reactions they
trigger [31] and there is evidence that the protective effect of BCG
vaccination against tuberculosis meningitis varies among ethnically
divergent population groups [32]. Taken together, these data
suggest that, similar to tuberculosis susceptibility, host responsive-
ness may reflect specific host-BCG strain interactions. To test this
possibility, we compared the genetic control of closely related
strains of BCG in a mouse model of infection.
Recombinant congenic (RC) strains are a set of genetically
related inbred strains. In RC strains, discrete chromosomal
segments of donor genome (12.5%) are transferred onto a
recipient genetic background (87.5%) through a double backcross
and corresponding strains are derived by subsequent inbreeding
[33]. The AcB/BcA panel used in the present study was derived
from a reciprocal double backcross between C57BL/6J and A/J
[34], two mouse strains known to differ in their susceptibility to M.
bovis BCG strain Montreal [35]. Each RC strain is genetically
distinct with its own unique genome. The genomes of all RC
strains have been mapped extensively and represent frozen
replicas of recombinant progenitor genomes with known genomic
boundaries of chromosomal segments derived from the two
progenitor strains. A major advantage of RC strains over
conventional crosses is that any phenotype can be measured
repeatedly in genetically identical mice of a RC strain, greatly
improving the accuracy of the phenotypic estimates.
In the present study, 35 distinct AcB/BcA strains were infected
with a low dose of either BCG Pasteur or BCG Russia. A genetic
analysis of the bacillary counts in the spleen and lungs of these
strains identified general, as well as tissue- and BCG strain-specific
susceptibility loci for BCG infection. These results demonstrated
that the host response to mycobacteria reflects a genetically
controlled, joint effect of both host and pathogen. Our findings
established strain specific effects of the host-mycobacteria interplay
in the absence of selective pressure and, therefore, argue in favour
of additional host-mycobacterial adaptation during the co-
evolution of humans and mycobacteria.
Materials and Methods
Mice and ethics statement
A/J and C57BL/6J mice were purchased from the Jackson
Laboratory (Bar Harbor, Maine). Thirty-five independent RC
strains originally derived from a reciprocal double backcross
between the A/J and C57BL/6J progenitors [34] were purchased
from Emerillon Therapeutics Inc. (Montreal, Qc.). All mice were
housed in the rodent facility of the Montreal General Hospital.
Animal use protocols were approved by the Animal Care
Committee of McGill University and are in direct accordance
with the guidelines outlined by the Canadian Council on Animal
Care.
Bacterial strains
Recombinant BCG Russia (ATCC 35740) and Pasteur (ATCC
35734), were transformed with pGH1, an integrating vector that
inserts into the attB site of the mycobacterial genome and that
combines a firefly luciferase lux gene cassette, an integrase [int]
gene, a MOP promoter, and a hygromycin resistance [Hyg] gene
[31]. The pGH1 vector allows for growth on antibiotic-containing
media to reduce risk of contamination [36].
Infection of mice
BCG strains were grown on a rotating platform at 37uC in
Middlebrook 7H9 medium (Difco Laboratories, Detroit, Mich.)
containing 0.05% Tween 80 (Sigma-Aldrich, St. Louis, Mo.) and
10% albumin-dextrose-catalase (ADC) supplement (Becton Dick-
inson and Co., Sparks, Md.). At an optical density (OD600) of 0.4
to 0.5, bacteria were diluted in phosphate buffered saline (PBS) to
105 colony forming units (CFU)/ml. Mice were injected
intravenously with 103 to 104 CFU of BCG in 100 mL of PBS.
Inoculum doses were confirmed by plating on Middlebrook 7H10
agar (Difco Laboratories, Detroit, Mich.) supplemented with oleic
acid-albumin-dextrose-catalase (OADC) enrichment (Becton
Dickinson and Co., Sparks, Md.).
BCG load in target organs
Infected mice were sacrificed by CO2 inhalation after 1 and 6
weeks post-infection. Lungs and spleens were aseptically removed,
placed in 0.025% Saponin-PBS, and homogenized mechanically
using a Polytron PT 2100 homogenizer (Brinkman Instruments,
Westbury, NY). Homogenates were serially diluted tenfold and
plated on Middlebrook 7H10 agar supplemented with OADC
enrichment and containing hygromycin B (Wisent Inc., St.-Bruno,
Qc.). Bacterial enumeration was performed following a six-week
incubation at 37uC. For BCG Pasteur infection, a total of 221 and
175 mice were used at the week 1 and 6 time points, respectively.
Author Summary
Susceptibility to mycobacterial infection results from a
complex interaction between host and bacterial genetic
factors. To examine the effect of host and pathogen
genetic variability on the control of mycobacterial
infection, we infected a panel of genetically related
recombinant congenic (RC) mouse strains with two closely
related strains of Mycobacterium bovis BCG. Bacterial
counts of BCG Russia and BCG Pasteur were determined
in the lung and spleen at 1 and 6 weeks following infection
and used for genetic analysis. A novel analytical approach
was developed to perform genome-wide linkage analyses
using the RC strains. Comparative linkage analysis using
this model identified a strong genetic effect on chromo-
some 1 controlling counts of BCG Pasteur at 1 week and of
BCG Russia at 1 week and 6 weeks in the spleen. A locus
impacting on late BCG Russia counts in the lung and
spleen was identified on chromosome 11. Nine additional
loci were shown to control bacterial counts in a tissue-,
time-, and BCG strain-specific manner. Our findings
suggest that the host genetic control of mycobacterial
infection is highly dynamic and adapted to the stage of
pathogenesis and to the infecting strain. Such a high
degree of genetic plasticity in the host-pathogen interplay
is expected to favour evolutionary co-adaptation in
mycobacterial disease.
Comparative Host Genetics of Two Strains of BCG
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A total of 145 and 189 mice, respectively, were used at 1 and 6
weeks for BCG Russia infection.
Genotyping
Strains of the AcB/BcA panel were genotyped for 625
microsatellite markers spanning the entire genome with an
average distance of 2.6 cM [34]. Based on Build 36.1 of Mouse
Genome Informatics (MGI) Mouse Genome Database, six
markers with reassigned positions were removed from the current
analysis [37].
Statistical analysis
The first QTL model was the linear model
y~ Xbz qm gmz e
where y represents a vector with the individual total count of
bacteria (log10CFU); qm is a vector with each entry being an
indicator variable of the genotype BB at the marker position m
with gm being its associated effect (major gene effect); X is a matrix
of fixed covariates (a constant and gender in our main model) and
its corresponding parameter vector b; e is a vector of independent
and identically distributed random variables representing the error
term with E eð Þ~0 and Var eð Þ~s2I. At each marker position m,
M-estimates of the parameters and a t-statistic were computed.
The genome-wide corrected p-values were obtained by bootstrap
under the hypothesis that there is no major gene, i.e., re-sampling
under the reduced model
y~ Xbz e
Mean confidence bounds at each marker were defined as twice the
standard error around the marker’s group mean without
considering gender effect in the model.
In order to account for the genetic background, a second linear
model of the form
y~ Xbz Zuz qmgmze
was employed, i.e., our second model was the mixed model
resulting from adding a random component, Zu, to our original
model, where u is a random vector associated to the genetic
background of each RCS and Z is the design matrix associating
the RCS effect to the phenotype y. The assumptions for this model
component were E uð Þ~0 and Var uð Þ~s2uG, with s2uw0 being an
unknown constant and G a positive definite-matrix (in fact, a
background correlation matrix which is a function of length of the
segments identical by descent shared amongst strains) assumed to
be known, although a genomic estimate of it was previously
obtained. At each marker position m, iteratively, estimates of fixed
effect parameters and the variance components were obtained
under this model and a t-statistic of the same form as before was
computed. The genome-wide corrected p-values were obtained by
bootstrap under the hypothesis that there is no major gene, i.e., re-
sampling under the reduced model
y~XbzZuze:
More details of estimation and testing are given in Methods S1.
Evidence was considered significant for linkage when single-point
regression analysis at the markers was P,0.01.
Results
We determined the bacillary load of BCG strains Pasteur and
Russia in the lungs and spleens of C57BL/6J and A/J mice
following a low dose (,36103 bacilli) intravenous injection of
bacilli. Pulmonary counts of BCG Pasteur were below the limit of
detectability (80 bacilli/lung) at weeks 1 and 6 post infection but
showed a modest peak of approximately 100 bacilli/lung at week 3
(Figure 1). This suggested limited dispersion and growth of BCG
Pasteur in the lungs. In addition, there was no detectable
difference in the pulmonary load of BCG Pasteur between
C57BL6/J and A/J mice. By contrast, we observed an increase
of 1–1.5 log CFU in the spleens between weeks 1 and 3 post
infection that was followed by a 1 log decrease at week 6. The
splenic bacillary burden of BCG Pasteur was substantially higher
in C57BL/6J mice at weeks 1 and 3. BCG Russia showed a
constant increase of pulmonary CFU from week 1 to week 6. In
the spleen, growth of BCG Russia lagged growth of Pasteur and
did not show evidence for a peak at 3 weeks post infection, as was
observed for Pasteur (Figure 1). Overall, the pattern of tissue CFU
for BCG Pasteur strongly resembled the one described for BCG
Montreal which has previously been shown to be under Nramp1
control [35,38]. The kinetics of lung and spleen bacillary counts of
BCG Russia were distinct from the previously described BCG
growth patterns.
To investigate the genetic control of in-vivo growth of BCG
Russia and BCG Pasteur, mice from a panel of 35 AcB/BcA RC
strains were intravenously challenged with a low dose (3–56103
bacilli) of BCG Russia or BCG Pasteur. The number of colony
forming units (CFU) in the spleen and lung was used as the
phenotype for the genetic analysis. CFU were determined at 1
week and 6 weeks post infection since it is well established that at 3
weeks, the Nramp1 gene dominates the host response to BCG
Montreal [38], making it potentially more difficult to discern
additional genetic control elements.
To best indicate the effect of genotype on CFU, all RCS were
stratified according to genotype at each marker, i. e. AA for
markers on chromosomal segments derived from A/J or BB for
chromosomal segments derived from C57BL/6J. Mice of all RCS
with a given genotype were then used to obtain the mean and 95%
confidence interval of their pulmonary and splenic CFU. This
presentation allowed to graphically depict the effect of both
marker genotype and of the general strain background on CFU.
Results for the spleen and lung for both BCG strains are presented
in Figures 2 and 3. A clear impact of strain background on
susceptibility to BCG in the spleen at 1 week post infection was
evidenced by the larger bacillary counts in mice of the BB
genotype across most chromosomes (Figure 2). The strong strain
background effect on splenic CFU was resolved by 6 weeks post
infection, particularly for BCG Pasteur where differences in
splenic bacillary burden appeared negligible across all markers
(Figure 2). By contrast, CFU differences in BCG Russia were
observed for several small chromosomal segments possibly
suggesting the presence of specific genetic loci (Figure 2). As in
the parental strains, pulmonary burdens were at the limit of
detectability at week 1 for both Russia and Pasteur, and week 6 for
Pasteur. However, at the 6-week endpoint, preferential replication
of BCG Russia was observed in mice bearing specific A/J-derived
chromosomal segments, particularly at the distal portion of
chromosome 11 (Figure 3).
Comparative Host Genetics of Two Strains of BCG
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Markers where the mean CFU of the AA and BB genotype
groups diverged were indicative of chromosomal regions that
potentially harboured a BCG susceptibility locus. To confirm the
potential linkage of these chromosomal segments to bacterial
burden, a genetic analysis comparing mice of the AA to BB
genotype was performed. The initial analysis compared genotype
groups without taking into account the genetic background of
the strain or the gender of the mouse (incomplete model). As
expected, markers significantly linked to bacterial burden
corresponded well with chromosomal regions where the two
genotypes differed (Figures 2 and 3; Figures S1 to S3). From this
analysis, the genetic control of BCG Pasteur and Russia splenic
infection appeared to be highly multigenic at the early time point.
Employing a very stringent level of significance (P,0.0003),
quantitative trait loci (QTL) were identified across 8 and 15
different chromosomes for BCG Pasteur and Russia, respectively
(Figure S1). At the 6 week endpoint, a locus was identified on
chromosome 1 for splenic BCG Russia load whereas genetic
effects were not detected for BCG Pasteur load (Figure S2).
Pulmonary CFU of BCG Russia was controlled by a locus on
chromosome 11 while for BCG Pasteur a locus was identified on
chromosome 8 (Figure S3).
Visual inspection of CFU across genotypes suggested a strong
impact of strain background on bacillary loads. To account for the
potential impact of background genes on linkage peaks, we
developed a main model that accounted for the genetic
background and gender of the mice. The number of loci identified
by the main model was reduced relative to the incomplete model,
particularly at the 1 week time point (Figures S4 and S5, and
Table 1). For lung CFU, the locus on chromosome 11 remained
that impacted on bacillary load of BCG Russia at 6 weeks post
infection (Figure 4). No genetic effect was detected for pulmonary
load of BCG Pasteur which is consistent with the very limited
growth of BCG Pasteur in the lungs of all mice (data not shown).
In contrast to the lung, the genetic control of splenic bacillary
load remained largely multigenic even after correction for strain
background effects. For BCG Russia at 1 week post infection, a
single locus on chromosome 1 (36.9 cM–48.8 cM) was found to
control splenic load (Figure S4). At 6 weeks post infection, the
genetic control of BCG Russia was multigenic (Figure S5). In
Figure 1. Replication of BCG in the lungs and spleen of A/J and C57BL/6J mice. A/J and C57BL/6J were intravenously infected with a low
dose (3–56103) of either BCG Pasteur (A, C) or BCG Russia (B, D). The number of CFU in the lungs (A, B) and spleen (C, D) was determined at 1, 3, and 6
weeks post-infection. Bacterial counts of BCG Pasteur and BCG Russia were compared in A/J and C57BL/6J mice by two-way ANOVA. Differences in
the pulmonary counts of BCG Pasteur and BCG Russia between A/J and C57BL/6J failed to reach significance. However, there was a significant
difference in the splenic loads of BCG Pasteur (P,0.004) and BCG Russia (P,0.0001) between the two strains of mice. These results are representative
of at least two experiments. Four to 13 mice were used at each time-point. Data at each time point are the mean log10CFU and SD. White, A/J; grey,
C57BL/6J.
doi:10.1371/journal.ppat.1001169.g001
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Figure 2. Spleen bacillary counts relative to A/J and C57BL/6J-derived chromosomal segments in RC mice. AcB and BcA mice were
infected with BCG Russia (A, B) or BCG Pasteur (C, D) and spleen bacterial counts were determined at 1 week (A, C) and 6 weeks (B, D) post-infection.
RC mice were stratified by genotype (AA in black or BB in blue) at each microsatellite marker and the mean log10CFU (solid line) as well as twice the
standard error confidence bounds (hatched area) were determined for the two groups of mice. Gaps between the mean CFU of the AA and BB
genotype are indicative of markers where the two groups differed. Chromosomal positions are given in centimorgans (cM).
doi:10.1371/journal.ppat.1001169.g002
Comparative Host Genetics of Two Strains of BCG
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Figure 3. Lung bacillary counts relative to A/J and C57BL/6J-derived chromosomal segments in RC mice. Pulmonary bacterial loads in
RC mice intravenously infected with BCG Russia (A, B) or BCG Pasteur (C, D) were determined at 1 week (A, C) and 6 weeks (B, D) post-infection. RC
mice were stratified by genotype (AA in black or BB in blue) at each microsatellite marker and the mean log10CFU (solid line) and confidence bounds
(hatched area) were determined for the two groups of mice. A divergence in the mean CFU of the AA and BB genotype groups represent
chromosomal regions where the two groups differed. Chromosomal positions are given in centimorgans (cM).
doi:10.1371/journal.ppat.1001169.g003
Comparative Host Genetics of Two Strains of BCG
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addition to the chromosome 1 locus (32.8–55.1 cM), loci were
detected on chromosome 6 (45.5–46.3 cM), chromosome 11
(47.67 cM) and chromosome 19 (51 cM). Splenic load of BCG
Pasteur at 1 week post infection was controlled by loci on
chromosome 2 (10–15 and 22.5–26.2 cM), chromosome 7 (63.5–
65.6 cM) and the X chromosome (37–40.2 cM). Additional
weaker effects were identified on chromosome 3 (33.7 and
58.8 cM), chromosome 6 (63.9 cM), chromosome 10 (3 cM),
and chromosome 17 (23.2 cM). A major gene effect detected on
chromosome 1 (17–58.5 cM) overlapped the chromosome 1 locus
controlling BCG Russia infection (Figure S4, Table 1). Genetic
control elements were not detected in response to BCG Pasteur
infection at the 6 week time point (data not shown). The inverse
complexity of BCG Pasteur (multigenic at 1 week; no genes at
week 6) and BCG Russia (a single gene at week 1, multigenic at
week 6) reflects differences in the replication pattern of the
bacteria: BCG Russia showed a delayed onset of growth that
continued at week 6 while BCG Pasteur showed rapid initial
growth with a strong decline of CFU at week 6 as compared to
week 3.
The chromosome 1 locus significant for linkage early during
BCG Pasteur infection and at the early and late phase of BCG
Russia infection was indistinguishable from Nramp1. Employing
what we termed the ‘‘conditional model,’’ we determined whether
the additional linkage peaks were conditional on the Nramp1 gene.
For this the main model was modified to adjust for the effect of
Nramp1 by adding a column with the BB genotype indicator at the
Nramp1 position to the matrix X. Chromosomal regions identified
at the week 1 time point of both BCG Pasteur and BCG Russia
infection were no longer significant for linkage following
correction for the chromosome 1 locus (data not shown). Similarly,
the genetic effects detected on chromosome 6 and 19 were no
longer significant at the 6 week time point of BCG Russia
infection. However, the linkage hit detected on chromosome 11
(47.67 cM) retained its significance. By contrast, a secondary peak
detected only for splenic CFU immediately proximal to this locus
did not reach significance (Figure 5). Finally, an additional locus
was localized to chromosome 13 (73–75 cM) (Figure 5).
Discussion
RC strains are particularly useful to establish pathways of
causality in complex read-outs such as immune reactivity and are
well suited to track gene-gene interactions [33]. However, RC
strains have also proven useful for positional identification of
disease susceptibility loci by employing RC strains with extreme
phenotypes in subsequent genetic crosses [39,40,41]. A third
application of RC strains is the genome-wide identification of
quantitative trait loci (QTL) in complex diseases. This feature of
RC stains is particularly attractive since it allows the measurement
Figure 4. Genetic control of late pulmonary bacillary counts of BCG Russia. Linkage analysis of BCG Russia pulmonary counts at the 6-week
time point was performed with background and gender-adjustment. A single locus controlling BCG Russia pulmonary counts was identified on
chromosome 11. Chromosomal positions are given in centimorgans (cM).
doi:10.1371/journal.ppat.1001169.g004
Table 1. Summary of significant linkage peaks obtained
using the main and conditional models.
Strain Organ Day Main model
Conditional
model
BCG Pasteur Spleen 7 Chrs. 1, 2, 3, 6, 7, 10, 17, X (Chr. 1)a
42 - b N/A
Lung 7 - N/A
42 - N/A
BCG Russia Spleen 7 Chr. 1 (Chr. 1)
42 Chrs. 1, 6, 11, 19 Chrs. (1), 11, 13
Lung 7 - N/A
42 Chr. 11 N/A
Chr., chromosome; N/A, not applicable.
a(Chr. 1), exclusion of markers on chromosome 1 to adjust for major genetic
effect.
b-, no significant genetic effects detected.
doi:10.1371/journal.ppat.1001169.t001
Comparative Host Genetics of Two Strains of BCG
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of quantitative traits in many genetically identical mice belonging
to the same strain which greatly increases the accuracy of trait
determination. A genome-wide scan for the presence of QTL can
then be conducted among the relatively limited number of RC
strains in each panel. This is highly efficient compared to the
breeding and genotyping of hundreds of mice in traditional
backcross or F2 based genome-wide mapping studies. For
example, a recent study used the AcB/BcA RC strain panel to
localize a large number of asthma susceptibility loci across the
genome [42]. A potential problem that is faced in these speedy
genome-wide scans in RC strains is the confounding impact of
strain background and of strong susceptibility loci on the overall
pattern of QTLs mapped. We have developed a new analytical
methodology that overcomes both of these potentially confounding
limitations while conducting genome-wide QTL mapping in RC
strains. Our results demonstrate the ease of genome-wide scanning
in RC strains and the importance of adjusting especially on strain
background to achieve reliable QTL identification.
Our ability to detect the Nramp1 genomic region also served as
an internal validation of the analytical approach. Another
interesting observation was the loci that could only be detected
in connection with Nramp1. Once the analysis was adjusted on the
Nramp1 gene, these loci were no longer significant for linkage. The
most parsimonious explanation for this effect is that these loci are
interacting with Nramp1. Why we would detect a large number of
genes that interact with Nramp1 in the genetic control of BCG
Pasteur as compared to BCG Russia is not known but may reflect
the differences in pathogenesis between the two BCG strains. For
BCG Pasteur, putatively interacting genes were detected at 3
weeks post infection while for BCG Russia such interacting loci
were observed at the 6 week time point. At 3 weeks, BCG Pasteur
shows a sharp peak of splenic bacillary burden while the growth of
BCG Russia continues well past 6 weeks before a slow and gradual
reduction of splenic burden becomes evident after 12 weeks of
infection (data not shown). While the interpretation of our results
as Nramp1 interacting loci appears reasonable, it is important to
realize that this conclusion needs further direct experimental
validation. However, if correct, the mapping tools presented in this
paper would provide a very powerful approach for the
identification of interacting loci which is still a major obstacle in
complex trait analysis in both human and model animals.
The study of the impact of strain variability of M tuberculosis on
disease expression is of considerable interest for the implementa-
tion of tuberculosis control measures. An increasing body of
evidence suggests that different strains/lineages of M. tuberculosis
display substantial differences in their pathogenic potential [8,9].
In addition, evidence is emerging that genetic variability among
BCG vaccine strains is a potent factor in modulating BCG induced
anti-tuberculosis immunity [31]. This mycobacterial strain vari-
ability reflects an even greater divergence in host responsiveness to
both BCG and M. tuberculosis that is largely under host genetic
control (reviewed in [43]). These observations raise the question if
host and mycobacterial variability are independent of each other.
If independent, we would expect hosts to display a spectrum of
responsiveness from highly resistant to highly susceptible irrespec-
tive of the infecting mycobacterial strain. Similarly, M. tuberculosis
strains would vary from highly virulent to mildly virulent across all
hosts. Alternatively, it is possible that ‘‘susceptibility’’ and
‘‘virulence’’ are not absolute but rather reflect specific combina-
tions of mycobacterial strain and human host. The latter possibility
is supported by recent observations of preferential associations of
tuberculosis lineages with ethnic groups that may reflect co-
adaptation of M. tuberculosis and its human host [10]. Moreover, a
number of host genetic association studies have reported a
preferential association of tuberculosis susceptibility variants with
specific M. tuberculosis lineages [12,13,14]. The results of our study
obtained in a highly controlled experimental setting support the
hypothesis of host – pathogen specific genetic ‘‘fits.’’ Hence,
Figure 5. Linkage analysis of late spleen bacillary counts contingent on the chromosome 1 locus. Linkage analysis was performed with
an adjustment for the locus on chromosome 1 which had a major effect on the splenic bacillary counts of BCG Russia at the 6-week time point. The
loci identified on chromosomes 6 and 19 were conditional upon the chromosome 1 locus and lost their significance when adjusted. The genetic
effect detected on chromosome 11 was independent of the chromosome 1 locus and maintained its significance. An additional locus was localized to
chromosome 13. Chromosomal positions are given in centimorgans (cM).
doi:10.1371/journal.ppat.1001169.g005
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human susceptibility to tuberculosis may only become tractable by
jointly considering host and pathogen genetic backgrounds.
By conducting a genome-wide mapping of loci that impact on
the splenic and pulmonary burden following a low dose infection
with two strains of BCG, we revealed a divergent pattern of
susceptibility loci. An unexpected result was the pronounced
dynamic of genetic loci impacting on bacillary counts. This
observation demonstrated how different genetic control elements
came into play as the BCG infection advanced and further
emphasized the intimate interplay between host genetics and
pathogenesis. Perhaps less surprising was the large difference in the
number of loci involved in the control of splenic vs pulmonary
bacillary counts. BCG Pasteur shows little dissemination and
growth in the lungs of infected mice and the absence of
susceptibility loci was therefore expected. However, BCG Russia
reaches bacillary counts in the lungs that are similar to those in the
spleen. Yet, only one susceptibility locus on chromosome 11 was
detected to impact on pulmonary counts while splenic counts are
under more complex control. It is interesting that a locus on
chromosome 1 which is indistinguishable from the Nramp1 gene
had by far the strongest impact on bacillary burden in both BCG
Pasteur and Russia, but this effect was limited to splenic counts. By
contrast, the chromosome 11 locus was detected only for BCG
Russia but in both the spleens and lungs. The results therefore
indicate that host genetic control is characterized by very strong
common control elements that act in a tissue –specific manner,
and by somewhat weaker BCG strain specific susceptibility genes
that are not tissue specific. Together these data indicate that host
genetic control of mycobacterial replication is sensitive to the
particular strains but also to differences in disease manifestations
(here, lung vs spleen). Interestingly, the strongest genetic effect ever
found in human studies was found in an outbreak of tuberculosis
in Northern Canada [44]. During this outbreak, all cases had been
infected from a single index case, i.e. a single bacterial strain [45].
A fine tuned host genetic response to mycobacteria might explain
why it has been difficult to reproducibly detect strong host genetic
effects in human tuberculosis. Consequently, future genetic studies
of tuberculosis susceptibility might need to be adjusted on the
detailed clinical picture and infecting M. tuberculosis strain.
Supporting Information
Methods S1 Details of estimation, bootstrap and testing.
Found at: doi:10.1371/journal.ppat.1001169.s001 (0.05 MB PDF)
Figure S1 Linkage analysis of early splenic counts independent
of the genetic background. Bacillary counts of BCG Russia and
BCG Pasteur in the spleen of RC mice at the week 1 time point
were used for QTL analysis. AA and BB genotype groups were
analyzed without taking into account the gender or genetic
background of the RC mice. Significant evidence for linkage was
detected across 15 different chromosomes for BCG Russia (A) and
across 8 different chromosomes for BCG Pasteur (B) at the week 1
time point. Chromosomal positions are given in centimorgans
(cM).
Found at: doi:10.1371/journal.ppat.1001169.s002 (1.83 MB TIF)
Figure S2 Linkage analysis of late splenic counts independent of
the genetic background. Bacterial numbers of BCG Russia and
BCG Pasteur in the spleen of RC mice at the week 6 time point
were used for linkage analysis. Significant linkages were detected
on chromosomes 1 and 19 for BCG Russia (A) whereas no
significant evidence for linkage was detected for BCG Pasteur (B).
Chromosomal positions are given in centimorgans (cM).
Found at: doi:10.1371/journal.ppat.1001169.s003 (1.59 MB TIF)
Figure S3 Linkage analysis of late pulmonary counts indepen-
dent of the genetic background. QTL analysis was performed
using pulmonary counts of BCG Russia and BCG Pasteur at the
week 6 time point. Loci controlling pulmonary bacterial numbers
were identified on chromosome 11 for BCG Russia (A) and
chromosome 8 for BCG Pasteur (B). Chromosomal positions are
given in centimorgans (cM).
Found at: doi:10.1371/journal.ppat.1001169.s004 (1.61 MB TIF)
Figure S4 Genetic control of early spleen bacillary counts of
BCG Russia and BCG Pasteur. Linkage analysis of splenic
bacterial counts at the week 1 time point was performed with an
adjustment for strain genetic background and gender. A single
locus on chromosome 1 was identified in response to early BCG
Russia infection (A). Loci linked to splenic BCG Pasteur counts
were detected on chromosomes 1, 2, 3, 6, 7, 10, 17 and X at the
week 1 time point (B). Chromosomal positions are given in
centimorgans (cM).
Found at: doi:10.1371/journal.ppat.1001169.s005 (1.69 MB TIF)
Figure S5 Genetic control of late spleen bacillary counts
following infection of the RC strains with BCG Russia.
Background- and gender-adjusted QTL analysis was performed
using spleen counts of BCG Russia at the 6-week endpoint. A locus
on chromosome 1 had a major effect on the bacterial numbers of
BCG Russia. Additional loci were detected on chromosomes 6, 11,
and 19. Chromosomal positions are given in centimorgans (cM).
Found at: doi:10.1371/journal.ppat.1001169.s006 (0.73 MB TIF)
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